Kits, Annika http://orcid.org/0000-0003-3737-3161
Al-Saadi, Jonathan http://orcid.org/0000-0002-8832-7176
De Luca, Francesca http://orcid.org/0000-0001-7131-3248
Janzon, Fredrik
Mazya, Michael V. http://orcid.org/0000-0002-0377-3506
Lundberg, Johan http://orcid.org/0000-0003-2379-8695
Sprenger, Tim http://orcid.org/0000-0001-7037-8605
Skare, Stefan http://orcid.org/0000-0001-5403-2153
Delgado, Anna Falk http://orcid.org/0000-0003-4389-5089
Funding for this research was provided by:
Stockholms Läns Landsting
Åke Wiberg Stiftelse
iShizu Matsumurais donation
Magnus Bergvalls Stiftelse
Karolinska Institutet grant faculty fund
Eurostars through Horizon Europe
GE Healthcare
Karolinska Institute
Article History
Received: 7 January 2024
Accepted: 4 March 2024
First Online: 11 March 2024
Compliance of ethical standards
:
: Tim Sprenger is a Clinical Research Scientist at GE Healthcare, and Stefan Skare receives research support from GE Healthcare through the institution; the authors confirm that there has been no financial support for this work that could have influenced its outcome. Other authors declare no conflict of interest.
: The study was approved by the Swedish ethical review authority (2023–50734-02). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent for this retrospective study was waived by the Swedish ethical review authority.
: Stefan Skare and Tim Sprenger are the creators of the NeuroMix sequence.